DZIP3
Basic information
Region (hg38): 3:108589705-108694840
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DZIP3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 52 | 57 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 52 | 4 | 2 |
Variants in DZIP3
This is a list of pathogenic ClinVar variants found in the DZIP3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-108605423-A-G | Benign (Jun 19, 2018) | |||
3-108608103-A-G | not specified | Uncertain significance (Jan 09, 2024) | ||
3-108608108-C-G | not specified | Uncertain significance (Nov 30, 2022) | ||
3-108608112-G-A | not specified | Uncertain significance (Jan 29, 2024) | ||
3-108608118-A-G | not specified | Uncertain significance (May 18, 2023) | ||
3-108611313-C-G | not specified | Uncertain significance (Feb 23, 2023) | ||
3-108616559-A-G | not specified | Uncertain significance (Oct 30, 2023) | ||
3-108616599-G-A | not specified | Uncertain significance (Mar 26, 2024) | ||
3-108616623-C-T | not specified | Uncertain significance (Jul 08, 2022) | ||
3-108624511-G-A | not specified | Uncertain significance (Apr 25, 2022) | ||
3-108624534-A-G | Benign (Jun 29, 2018) | |||
3-108625845-G-T | not specified | Uncertain significance (Jan 26, 2022) | ||
3-108625856-A-C | not specified | Uncertain significance (Jul 16, 2021) | ||
3-108625942-G-A | not specified | Uncertain significance (Nov 29, 2023) | ||
3-108625944-G-A | not specified | Uncertain significance (Sep 29, 2022) | ||
3-108629109-G-C | not specified | Uncertain significance (Jul 17, 2024) | ||
3-108632987-G-A | not specified | Uncertain significance (Jul 11, 2023) | ||
3-108633005-C-T | not specified | Uncertain significance (Apr 26, 2023) | ||
3-108633020-T-G | not specified | Uncertain significance (Jan 09, 2024) | ||
3-108633022-G-C | not specified | Uncertain significance (Sep 26, 2023) | ||
3-108633032-G-A | not specified | Uncertain significance (May 23, 2024) | ||
3-108633046-G-A | not specified | Uncertain significance (Nov 08, 2024) | ||
3-108633068-A-G | not specified | Uncertain significance (Jan 31, 2022) | ||
3-108634887-T-C | not specified | Uncertain significance (May 10, 2024) | ||
3-108634920-A-T | not specified | Uncertain significance (Jun 26, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DZIP3 | protein_coding | protein_coding | ENST00000361582 | 31 | 105165 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.65e-13 | 1.00 | 125625 | 0 | 123 | 125748 | 0.000489 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.712 | 549 | 598 | 0.918 | 0.0000290 | 8013 |
Missense in Polyphen | 148 | 163.53 | 0.90501 | 2211 | ||
Synonymous | 0.501 | 193 | 202 | 0.955 | 0.00000999 | 2117 |
Loss of Function | 3.96 | 33 | 68.4 | 0.483 | 0.00000324 | 907 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000773 | 0.000758 |
Ashkenazi Jewish | 0.000398 | 0.000397 |
East Asian | 0.000509 | 0.000381 |
Finnish | 0.00109 | 0.00106 |
European (Non-Finnish) | 0.000487 | 0.000457 |
Middle Eastern | 0.000509 | 0.000381 |
South Asian | 0.000653 | 0.000588 |
Other | 0.000536 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: E3 Ubiquitin ligase proteins mediate ubiquitination and subsequent proteasomal degradation of target proteins. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin- conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Able to specifically bind RNA. {ECO:0000269|PubMed:12538761}.;
- Pathway
- Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
(Consensus)
Recessive Scores
- pRec
- 0.0953
Intolerance Scores
- loftool
- 0.570
- rvis_EVS
- -1.1
- rvis_percentile_EVS
- 6.91
Haploinsufficiency Scores
- pHI
- 0.0836
- hipred
- N
- hipred_score
- 0.372
- ghis
- 0.577
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.439
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dzip3
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- protein polyubiquitination
- Cellular component
- cytoplasm
- Molecular function
- RNA binding;ubiquitin-protein transferase activity;protein binding;phosphatase binding;polyubiquitin modification-dependent protein binding;metal ion binding;ubiquitin protein ligase activity